GlassScriptPhysician profile
Salmaan Jawaid
NPI 1467746503
$129,683.94
in general payments reported to CMS, 2019-2025
25 companies · $23K in 2025
The $23K reported for 2025 was more than what 95% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $18.39 · 2021: $6,888 · 2022: $7,099 · 2023: $34K · 2024: $44K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $35K · Consulting Fee: $34K · Food and Beverage: $23K · Travel and Lodging: $9,784.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,675.00 |
| Consulting Fee | $33,788.41 |
| Food and Beverage | $23,279.42 |
| Travel and Lodging | $9,784.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $66,166.78 | 2019-2025 | Overstitch Endoscopic Suturing System, Resolution 360 Clip, General - Therapies |
| Creo Medical INC. | $33,926.08 | 2021-2024 | Speedboat Ultraslim (Sb1l), Speedboat |
| Conmed Corporation | $11,512.58 | 2021-2025 | Gore Viabil, Beamer System, Conmed Generators |
| Lumendi LLC | $9,095.66 | 2020-2024 | |
| Micro-Tech Endoscopy USA, INC. | $2,362.21 | 2022-2025 | Endorotor |
| Olympus Corporation of The Americas | $1,531.95 | 2019 | |
| 3-D Matrix, INC. | $1,406.04 | 2024 | |
| Abbvie INC. | $1,165.41 | 2022-2025 | |
| Olympus Corporation | $550.00 | 2025 | |
| Applied Medical Resources Corporation | $375.00 | 2025 | |
| Medtronic, INC. | $259.76 | 2025 | Endoflip, Nexpowder, Sharkcore |
| Apollo Endosurgery US INC | $250.04 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $178.89 | 2021-2025 | Entyvio, Eohilia |
| Fujifilm Healthcare Americas Corporation | $140.55 | 2025 | |
| Enterra Medical, INC. | $133.07 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $127.98 | 2020-2025 | |
| Amgen INC. | $118.50 | 2025 | Uplizna |
| Janssen Biotech, INC. | $87.78 | 2022-2025 | Tremfya, Stelara |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.96 | 2022-2025 | Xifaxan |
| Ovesco Endoscopy USA, INC. | $74.75 | 2025 | |
| Olympus Latin America, INC. | $60.68 | 2019 | |
| Alcresta Therapeutics, INC. | $25.00 | 2022 | |
| Redhill Biopharma INC. | $21.23 | 2022 | |
| Olympus America INC. | $20.60 | 2021 | |
| Novo Nordisk INC | $18.44 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salmaan Jawaid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.